Cargando…

α‐Synuclein in blood cells differentiates Parkinson’s disease from healthy controls

OBJECTIVE: To determine whether blood cells expressed α‐Syn can differentiate Parkinson’s disease (PD) from healthy controls (HC). METHODS: The concentrations of α‐Syn were determined in samples of blood cell pellets using a quantitative Lipid‐ELISA assay. In addition, the levels of total protein, h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abd Elhadi, Suaad, Grigoletto, Jessica, Poli, Maura, Arosio, Paolo, Arkadir, David, Sharon, Ronit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6917335/ https://www.ncbi.nlm.nih.gov/pubmed/31742923 http://dx.doi.org/10.1002/acn3.50944

Ejemplares similares

A role for α-Synuclein in axon growth and its implications in corticostriatal glutamatergic plasticity in Parkinson’s disease
por: Schechter, Meir, et al.
Publicado: (2020)

α-Synuclein Translocates to the Nucleus to Activate Retinoic-Acid-Dependent Gene Transcription
por: Davidi, Dana, et al.
Publicado: (2020)

Total and Proteinase K-Resistant α-Synuclein Levels in Erythrocytes, Determined by their Ability to Bind Phospholipids, Associate with Parkinson’s Disease
por: Abd-Elhadi, Suaad, et al.
Publicado: (2015)

α-Synuclein facilitates endocytosis by elevating the steady-state levels of phosphatidylinositol 4,5-bisphosphate
por: Schechter, Meir, et al.
Publicado: (2021)

Safety and Tolerability, Dose-Escalating, Double-Blind Trial of Oral Mannitol in Parkinson's Disease
por: Linetsky, Eduard, et al.
Publicado: (2022)

Loss of Corticostriatal Mu-Opioid Receptors in α-Synuclein Transgenic Mouse Brains
por: Grigoletto, Jessica, et al.
Publicado: (2022)

The regulation of catalase activity by PPAR γ is affected by α-synuclein
por: Yakunin, Eugenia, et al.
Publicado: (2014)

Higher levels of myelin phospholipids in brains of neuronal α-Synuclein transgenic mice precede myelin loss
por: Grigoletto, Jessica, et al.
Publicado: (2017)

Alpha-Synuclein and Parkinson’s Disease Motor and Non-Motor Symptoms: What Is New?
por: Grigoletto, Jessica, et al.
Publicado: (2022)

α-Synuclein and Anti-α-Synuclein Antibodies in Parkinson’s Disease, Atypical Parkinson Syndromes, REM Sleep Behavior Disorder, and Healthy Controls
por: Smith, Lynnae M., et al.
Publicado: (2012)

α-Synuclein Expression Selectively Affects Tumorigenesis in Mice Modeling Parkinson's Disease
por: Israeli, Eitan, et al.
Publicado: (2011)

Oral and intravenous transmission of α-synuclein fibrils to mice
por: Lohmann, Stephanie, et al.
Publicado: (2019)

Inhibiting α-Synuclein Oligomerization by Stable Cell-Penetrating β-Synuclein Fragments Recovers Phenotype of Parkinson's Disease Model Flies
por: Shaltiel-Karyo, Ronit, et al.
Publicado: (2010)

α-Synuclein inclusions in the skin of Parkinson's disease and parkinsonism
por: Rodríguez-Leyva, Ildefonso, et al.
Publicado: (2014)

The role of the endolysosomal pathway in α-synuclein pathogenesis in Parkinson’s disease
por: Smith, Jessica K., et al.
Publicado: (2023)

Salivary total α-synuclein, oligomeric α-synuclein and SNCA variants in Parkinson’s disease patients
por: Kang, Wenyan, et al.
Publicado: (2016)

α - synuclein and Parkinson’s disease: the first roadblock
por: Lin Chua, Christelle En, et al.
Publicado: (2006)

Immunological features of α-synuclein in Parkinson's disease
por: Roodveldt, Cintia, et al.
Publicado: (2008)

Models of α-synuclein aggregation in Parkinson’s disease
por: Giráldez-Pérez, Rosa María, et al.
Publicado: (2014)

Role of Apolipoproteins and α-Synuclein in Parkinson’s Disease
por: Emamzadeh, Fatemeh Nouri
Publicado: (2017)

The Role of α-Synuclein Oligomers in Parkinson’s Disease
por: Du, Xiao-yu, et al.
Publicado: (2020)

Biomarkers and the Role of α-Synuclein in Parkinson’s Disease
por: Du, Tingting, et al.
Publicado: (2021)

Ischemic stroke causes Parkinson’s disease-like pathology and symptoms in transgenic mice overexpressing alpha-synuclein
por: Lohmann, Stephanie, et al.
Publicado: (2022)

Increased Neuronal α-Synuclein Pathology Associates with Its Accumulation in Oligodendrocytes in Mice Modeling α-Synucleinopathies
por: Kisos, Haya, et al.
Publicado: (2012)

α-Synuclein Reactive Antibodies as Diagnostic Biomarkers in Blood Sera of Parkinson's Disease Patients
por: Yanamandra, Kiran, et al.
Publicado: (2011)

A longitudinal study on α-synuclein in blood plasma as a biomarker for Parkinson's disease
por: Foulds, Penelope G., et al.
Publicado: (2013)

Inflammatory Responses to Monomeric and Aggregated α-Synuclein in Peripheral Blood of Parkinson Disease Patients
por: Piancone, Federica, et al.
Publicado: (2021)

Copper(II) Binding to α-Synuclein, the Parkinson’s Protein
por: Lee, Jennifer C., et al.
Publicado: (2008)

α-Synuclein impairs macroautophagy: implications for Parkinson’s disease
por: Winslow, Ashley R., et al.
Publicado: (2010)

The Contribution of α-Synuclein Spreading to Parkinson's Disease Synaptopathy
por: Longhena, Francesca, et al.
Publicado: (2017)

The Convergence of Dopamine and α-Synuclein: Implications for Parkinson’s Disease
por: Mor, Danielle E, et al.
Publicado: (2018)

Mechanisms of α-Synuclein Induced Synaptopathy in Parkinson's Disease
por: Bridi, Jessika C., et al.
Publicado: (2018)

“Janus-Faced” α-Synuclein: Role in Parkinson’s Disease
por: Ray, Bipul, et al.
Publicado: (2021)

Initiation and progression of α-synuclein pathology in Parkinson’s disease
por: Tofaris, George K.
Publicado: (2022)

Adenosine A1 receptor ligands bind to α-synuclein: implications for α-synuclein misfolding and α-synucleinopathy in Parkinson’s disease
por: Jakova, Elisabet, et al.
Publicado: (2022)

Structural Ensembles of Membrane-bound α-Synuclein Reveal the Molecular Determinants of Synaptic Vesicle Affinity
por: Fusco, Giuliana, et al.
Publicado: (2016)

Iron as Therapeutic Target in Human Diseases
por: Gozzelino, Raffaella, et al.
Publicado: (2019)

Can Plasma α-Synuclein Help Us to Differentiate Parkinson’s Disease from Essential Tremor?
por: Albillos, Silvia M., et al.
Publicado: (2021)

Differential Diagnosis of Multiple System Atrophy-Parkinsonism and Parkinson's Disease Using α-Synuclein and External Anal Sphincter Electromyography
por: Cao, Zhentang, et al.
Publicado: (2020)

GM1 Ganglioside Modifies α-Synuclein Toxicity and is Neuroprotective in a Rat α-Synuclein Model of Parkinson’s Disease
por: Schneider, Jay S., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_3od46h4nk3j7ml2nn8qc0r1888